Cytotoxicity and cytokine production by bovine alveolar macrophages challenged with wild type and leukotoxin-deficient Mannheimia haemolytica

Ambagala, 1999, The leukotoxin of Pasteurella haemolytica binds to β2 integrins on bovine leukocytes, FEMS Microbiology Letters, 179, 161 Caswell, 1998, Expression of the neutrophil chemoattractant interleukin-8 in the lesions of bovine pneumonic pasteurellosis, Veterinary Pathology, 35, 124, 10.1177/030098589803500206 Confer, 1990, Molecular aspects of virulence of Pasteurella haemolytica, Canadian Journal of Veterinary Research, 54, S48 Confer, 1997, Serum antibody responses of cattle vaccinated with partially purified native Pasteurella haemolytica leukotoxin, Vaccine, 15, 1423, 10.1016/S0264-410X(97)84247-8 Confer, 2006, Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PLPE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge, Vaccine, 24, 2248, 10.1016/j.vaccine.2005.11.036 Highlander, 2001, Molecular genetic analysis of virulence in Mannheimia (Pasteurella) haemolytica, Frontiers in Bioscience, 6, D1128, 10.2741/Highland Highlander, 2000, Inactivation of Pasteurella (Mannheimia) haemolytica leukotoxin causes partial attenuation of virulence in a calf challenge model, Infection and Immunity, 68, 3916, 10.1128/IAI.68.7.3916-3922.2000 Hurvich, 1995, Model selection for extended quasi-likelihood models in small samples, Biometrics, 51, 1077, 10.2307/2533006 Jeyaseelan, 2001, Pasteurella (Mannheimia) haemolytica leukotoxin-induced cytolysis of bovine leukocytes: role of arachidonic acid and its regulation, Microbial Pathogenesis, 30, 59, 10.1006/mpat.2000.0410 Kenward, 1997, Small sample inference for fixed effects from restricted maximum likelihood, Biometrics, 53, 983, 10.2307/2533558 Kwong, 2002, Development of an ELISA for bovine IL-10, Veterinary Immunology and Immunopathology, 85, 213, 10.1016/S0165-2427(02)00007-7 Lafleur, 2001, Lipopolysaccharide enhances cytolysis and inflammatory cytokine induction in bovine alveolar macrophages exposed to Pasteurella (Mannheimia) haemolytica leukotoxin, Microbial Pathogenesis, 30, 347, 10.1006/mpat.2000.0438 Li, 1999, Lipopolysaccharide complexes with Pasteurella haemolytica leukotoxin, Infection and Immunity, 67, 2920, 10.1128/IAI.67.6.2920-2927.1999 Maheswaran, 1992, Effects of Pasteurella haemolytica A1 leukotoxin on bovine neutrophils: degranulation and generation of oxygen-derived free radicals, Veterinary Immunology and Immunopathology, 33, 51, 10.1016/0165-2427(92)90034-N Malazdrewich, 2001, Pulmonary expression of tumor necrosis factor α, interleukin-1β, and interleukin-8 in the acute phase of bovine pneumonic pasteurellosis, Veterinary Pathology, 38, 297, 10.1354/vp.38-3-297 Moore, 2001, Interleukin-10 and the interleukin-10 receptor, Annual Review of Immunology, 19, 683, 10.1146/annurev.immunol.19.1.683 Murphy, 1995, Hemolytic activity of the Pasteurella haemolytica leukotoxin, Infection and Immunity, 63, 3209, 10.1128/IAI.63.8.3209-3212.1995 Paulsen, 1995, Pasteurella haemolytica lipopolysaccharide-induced cytotoxicity in bovine pulmonary artery endothelial monolayers: inhibition by indomethacin, Veterinary Pathology, 32, 173, 10.1177/030098589503200211 Rice, 2007, Mannheimia haemolytica and bovine respiratory disease, Animal Health Research Reviews, 8, 117, 10.1017/S1466252307001375 Rottman, 1996, A reverse transcription-quantitative competitive polymerase chain reaction (RT-qcPCR) technique to measure cytokine gene expression in domestic mammals, Veterinary Pathology, 33, 242, 10.1177/030098589603300217 Tatum, 1998, Construction of an isogenic leukotoxin deletion mutant of Pasteurella haemolytica serotype 1: characterization and virulence, Microbial Pathogenesis, 24, 37, 10.1006/mpat.1997.0181 Thumbikat, 2003, Biological effects of two genetically defined leukotoxin mutants of Mannheimia haemolytica, Microbial Pathogenesis, 34, 217, 10.1016/S0882-4010(03)00033-0 Whiteley, 1990, Immunohistochemical localization of Pasteurella haemolytica A1-derived endotoxin, leukotoxin, and capsular polysaccharide in experimental bovine Pasteurella pneumonia, Veterinary Pathology, 27, 150, 10.1177/030098589002700302 Wyckoff, 2005, Recombinant bovine interleukin 2 enhances immunity and protection induced by Brucella abortus vaccines in cattle, Veterinary Microbiology, 111, 77, 10.1016/j.vetmic.2005.09.004